Cargando…

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

BACKGROUND: Nephrotoxicity is the major side effect that limits the dose of cisplatin that can be safely administered, and it is a clinical problem in cancer patients who received cisplatin combination chemotherapy. Recent evidence has demonstrated that patients with chronic kidney disease (CKD) hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Ko, Watanabe, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Ishikawa, Daisuke, Tanaka, Tomohiro, Nozaki, Koichiro, Kondo, Rie, Okajima, Masaaki, Miura, Satoru, Tanaka, Junta, Sakagami, Takuro, Koya, Toshiyuki, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Narita, Ichiei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793503/ https://www.ncbi.nlm.nih.gov/pubmed/26979596 http://dx.doi.org/10.1186/s12885-016-2271-8

Ejemplares similares

DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations
por: Nozaki, Koichiro, et al.
Publicado: (2014)

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells
por: Tanaka, Tomohiro, et al.
Publicado: (2017)

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
por: Watanabe, Satoshi, et al.
Publicado: (2011)

Prognostic significance of procalcitonin in small cell lung cancer
por: Ichikawa, Kosuke, et al.
Publicado: (2022)

Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)
por: Shoji, Satoshi, et al.
Publicado: (2022)

Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study
por: Shoji, Satoshi, et al.
Publicado: (2019)

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity
por: Arita, Masashi, et al.
Publicado: (2021)

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
por: Fujisaki, Toshiya, et al.
Publicado: (2021)

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
por: Sato, Yusuke, et al.
Publicado: (2021)

Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy
por: Watanabe, Satoshi, et al.
Publicado: (2020)

Henoch Schönlein purpura associated with pulmonary adenocarcinoma
por: Mifune, Daiki, et al.
Publicado: (2011)

Study Design and Baseline Profiles of Participants in the Uonuma CKD Cohort Study in Niigata, Japan
por: Kabasawa, Keiko, et al.
Publicado: (2020)

Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases
por: Saida, Yu, et al.
Publicado: (2019)

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC
por: Koyama, Kenichi, et al.
Publicado: (2022)

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)
por: Watanabe, Satoshi, et al.
Publicado: (2022)

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations
por: Sato, Miyuki, et al.
Publicado: (2019)

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)
por: Okajima, Masaaki, et al.
Publicado: (2021)

Determination of specific life changes on psychological distress during the COVID-19 pandemic
por: Kabasawa, Keiko, et al.
Publicado: (2021)

The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men
por: Michishita, Ryoma, et al.
Publicado: (2017)

The joint impact of habitual exercise and glycemic control on the incidence of chronic kidney disease (CKD) in middle-aged and older males
por: Michishita, Ryoma, et al.
Publicado: (2017)

Education, household income, and depressive symptoms in middle-aged and older Japanese adults
por: Hinata, Aya, et al.
Publicado: (2021)

Long-term Body Weight Gain After Maturity is Associated With the Incidence of Chronic Kidney Disease (CKD), Independent of Current Body Weight, in Middle-aged and Older Men
por: Michishita, Ryoma, et al.
Publicado: (2019)

Association of metabolic syndrome traits with urinary biomarkers in Japanese adults
por: Kabasawa, Keiko, et al.
Publicado: (2022)

Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors
por: Bamba, Yuuki, et al.
Publicado: (2019)

Increased presepsin levels are associated with the severity of fungal bloodstream infections
por: Bamba, Yuuki, et al.
Publicado: (2018)

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients
por: Kushiro, Kohei, et al.
Publicado: (2022)

Association of estimated dietary acid load with albuminuria in Japanese adults: a cross-sectional study
por: Kabasawa, Keiko, et al.
Publicado: (2019)

Influence of Adherence to Inhaled Corticosteroids and Inhaler Handling Errors on Asthma Control in a Japanese Population
por: Koya, Toshiyuki, et al.
Publicado: (2018)

Value of (18)F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Sqstm1–GFP knock-in mice reveal dynamic actions of Sqstm1 during autophagy and under stress conditions in living cells
por: Eino, Atsushi, et al.
Publicado: (2015)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial)
por: Sezai, Akira, et al.
Publicado: (2019)

An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2017)

Kidney morphological parameters measured using noncontrast-enhanced steady-state free precession MRI with spatially selective inversion recovery pulse correlate with eGFR in patients with advanced CKD
por: Otsuka, Tadashi, et al.
Publicado: (2017)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Diagnosis Patterns of CKD and Anemia in the Japanese Population
por: Kimura, Tomomi, et al.
Publicado: (2020)

Potassium Metabolism and Management in Patients with CKD
por: Yamada, Shinsuke, et al.
Publicado: (2021)

A Cluster Analysis of Bronchial Asthma Patients with Depressive Symptoms
por: Seino, Yo, et al.
Publicado: (2018)

Changes in Prevalence and Health Checkup Coverage Rate of Chronic Kidney Disease (CKD) after Introduction of Prefecture-Wide CKD Initiative: Results of the Kagawa Association of CKD Initiatives
por: Sofue, Tadashi, et al.
Publicado: (2021)

Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study
por: Iimuro, Satoshi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m721rhru6vkn4m9f27jpc33dc3